Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.
Journal Information
Full Title: Am J Clin Oncol
Abbreviation: Am J Clin Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"J.J.T., T.A.R., and E.P.B. are AREVA Med employees. R.F.M. joined the Scientific Advisory Board July 2015. The other authors declare no conflicts of interest."
Funding Disclosure
Evidence found in paper:
"Supported by AREVA Med and NIH CCTS grant 1UL1TR001417."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025